Regional approaches to monitoring drug quality
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: BLUM, Nancy (U.S. Pharmacopeia, Rockville, United States of America)
Counterfeiting drugs is big business; the demand for drugs is high and the cost of making fakes is low. The greater the costs of authentic medicines, the more likely consumers are to buy from unreliable sources, especially in countries with little or no drug regulatory control. Substandard medicines have been found in private pharmacies and in.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.